Net profit of Morepen Laboratories declined 14.48% to Rs 8.92 crore in the quarter ended December 2018 as against Rs 10.43 crore during the previous quarter ended December 2017. Sales rose 37.10% to Rs 212.16 crore in the quarter ended December 2018 as against Rs 154.75 crore during the previous quarter ended December 2017.

Powered by Capital Market - Live News

Net profit of Morepen Laboratories rose 0.72% to Rs 9.74 crore in the quarter ended December 2018 as against Rs 9.67 crore during the previous quarter ended December 2017. Sales rose 40.07% to Rs 198.32 crore in the quarter ended December 2018 as against Rs 141.59 crore during the previous quarter ended December 2017.

Powered by Capital Market - Live News

Morepen Laboratories will hold a meeting of the Board of Directors of the Company on 4 February 2019.

Powered by Capital Market - Live News

Morepen Laboratories Ltd rose 5.37% today to trade at Rs 21.6. The S&P BSE Healthcare index is up 0.64% to quote at 13930.61. The index is up 1.21 % over last one month. Among the other constituents of the index, Sun Pharma Advanced Research Company Ltd increased 4.46% and Sun Pharmaceuticals Industries Ltd added 3.83% on the day. The S&P BSE Healthcare index went down 6.92 % over last one year compared to the 1.98% surge in benchmark SENSEX.

Morepen Laboratories Ltd has lost 3.57% over last one month compared to 1.21% gain in S&P BSE Healthcare index and 2.14% rise in the SENSEX. On the BSE, 520 shares were traded in the counter so far compared with average daily volumes of 56062 shares in the past one month. The stock hit a record high of Rs 44.15 on 22 Jan 2018. The stock hit a 52-week low of Rs 19.2 on 10 Oct 2018.

Powered by Capital Market - Live News